journal article·2024-12-19Open access

Development of a Herb-Based Dietary Ingredient with Potential Nootropic Properties: From Bench to Bedside

Pau Navarro, Justyna Meissner, José Luis Mullor, Nuria Caturla, Jonathan Jones

Applied Sciences· Volume 14· Issue 24

Abstract

Cognitive decline is a natural process that occurs during aging. Several natural solutions called nootropics exist that can help mitigate this process. However, in some cases, there is a lack of scientific evidence on their potential mechanisms and efficacy. To this end, a total of nine different herb extracts with potential nootropic activity were evaluated. These herb extracts were tested in human neural stem cell cultures exposed to oxidative stress, where reactive oxygen/nitrogen species, cell survival and trophic factor expression were analyzed. Of these extracts, Salvia officinalis (sage) was observed to possess the most significant effect. Its combination with rutin demonstrated additional benefits than with only sage. A randomized, double-blind placebo-controlled clinical study was then performed, testing the effects of the combination at two different doses for 12 weeks in healthy volunteers aged 50+ with mild cognitive impairment. As a result, the blend significantly improved several characteristics related to memory, particularly memory recall, with a more noticeable effect in the higher dose. Therefore, this study reveals the potential nootropic effect of a blend comprising Salvia officinalis and rutin. This blend could be a candidate dietary ingredient with potential nootropic properties.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Medicinal Plants and Neuroprotection · Medicinal Plants and Bioactive Compounds · Neurological Disease Mechanisms and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Monteloeder SL, C. Miguel Servet 16, 03203 Elche, Spain

Bionos Biotech SL, Av. Fern. Abr. Martorell 106, 46026 Valencia, Spain

References (64)

Show source-provided references
2. Nootropic Medicinal Plants: Therapeutic Alternatives for Alzheimer’s Disease10.1016/j.hermed.2019.100291 ↗
3. Latest research in nootropic therapy of patients with chronic cerebral circulation insufficiency10.36740/WLek202405128 ↗
4. Malík, M., and Tlustoš, P. (2023). Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers. Plants, 12.10.3390/plants12061364 ↗
5. Bacopa monnieri Increases Cerebral Blood Flow in Rat Independent of Blood Pressure10.1002/ptr.4685 ↗
6. Effect of Different Extracts of Centella asiatica on Cognition and Markers of Oxidative Stress in Rats10.1016/S0378-8741(01)00394-4 ↗
7. Ginsenoside Rb2 Suppresses the Glutamate-Mediated Oxidative Stress and Neuronal Cell Death in HT22 Cells10.1016/j.jgr.2018.12.002 ↗
8. Bioavailability of Catechins from Guaraná (Paullinia cupana) and its Effect on Antioxidant Enzymes and other Oxidative Stress Markers in Healthy Human Subjects10.1039/C6FO00513F ↗
9. Modulation of Hydrogen Peroxide and Acrolein-Induced Oxidative Stress, Mitochondrial Dysfunctions and Redox Regulated Pathways by the Bacopa monniera Extract: Potential Implication in Alzheimer’s Disease10.3233/JAD-2010-091729 ↗
10. Nerve Growth Factor-Inducing Activity Of Hericium erinaceus In 1321n1 Human Astrocytoma Cells10.1248/bpb.31.1727 ↗
11. Sumiyoshi, E., Matsuzaki, K., Sugimoto, N., Tanabe, Y., Hará, T., Katakura, M., Miyamoto, M., Mishima, S., and Shido, O. (2019). Sub-Chronic Consumption of Dark Chocolate Enhances Cognitive Function and Releases Nerve Growth Factors: A Parallel-Group Randomized Trial. Nutrients, 11.10.3390/nu11112800 ↗
12. Acute Cocoa Flavanol Improves Cerebral Oxygenation Without Enhancing Executive Function at Rest or After Exercise10.1139/apnm-2016-0245 ↗
13. Malík, M., and Tlustoš, P. (2022). Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. Nutrients, 14.10.3390/nu14163367 ↗
14. Protective Effect of Rutin on Impairment of Cognitive Functions Due to Antiepileptic Drugs on Zebrafish Model10.4103/0253-7613.150357 ↗
15. BDNF is Essential to Promote Persistence of Long-Term Memory Storage10.1073/pnas.0711863105 ↗
16. Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders10.1155/2018/6241017 ↗
17. Office-and Bedside-Based Screening for Cognitive Impairment and the Dementias: Which Tools to Use, Interpreting the Results, and What are the Next Steps?10.1016/j.cger.2022.07.002 ↗
18. The Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review10.3233/JAD-170991 ↗
19. Neuroprotective Effects of Anthocyanins and its Major Component Cyanidin-3-O-Glucoside (C3G) in the Central Nervous System: An Outlined Review
20. Berry Anthocyanins as Novel Antioxidants in Human Health and Disease Prevention10.1002/mnfr.200700002 ↗
21. Bilberry Anthocyanin Extract Promotes Intestinal Barrier Function and Inhibits Digestive Enzyme Activity by Regulating the Gut Microbiota in Aging Rats10.1039/C8FO01962B ↗
22. Blueberry Supplementation Improves Memory in Older Adults10.1021/jf9029332 ↗
23. Dietary Blueberry Improves Cognition Among Older Adults in a Randomized, Double-Blind, Placebo-Controlled Trial10.1007/s00394-017-1400-8 ↗
24. Cognitive Response to Fish Oil, Blueberry, and Combined Supplementation in Older Adults with Subjective Cognitive Impairment10.1016/j.neurobiolaging.2017.12.003 ↗
25. Enhanced Task-Related Brain Activation and Resting Perfusion in Healthy Older Adults After Chronic Blueberry Supplementation10.1139/apnm-2016-0550 ↗
26. Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on its Properties, Mechanisms of Action, and Preclinical and Clinical Studies
27. Effect of Bacopa monnieri on Cognitive Functions in Alzheimer’s Disease Patients
28. Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial10.1155/2016/4103423 ↗
29. Effects of a Standardized Bacopa monnieri Extract o Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial10.1089/acm.2008.0018 ↗
30. Investigating Bacopa monnieri L. Therapeutic Potential for the Treatment of Neurological Diseases10.2174/0113816128288698240305094945 ↗
31. Examining the Nootropic Effects of a Special Extract of Bacopa monnieri on Human Cognitive Functioning: 90 Day Double-Blind Placebo-Controlled Randomized Trial10.1002/ptr.2537 ↗
32. Does Bacopa monnieri Improve Memory Performance in Older Persons? Results of a Randomized, Placebo-Controlled, Double-Blind Trial10.1089/acm.2009.0342 ↗
33. Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects10.1007/s40268-016-0157-5 ↗
34. Effects of Cholinesterase Inhibiting Sage (Salvia officinalis) on Mood, Anxiety and Performance on a Psychological Stressor Battery10.1038/sj.npp.1300907 ↗
35. Natural remedies for Alzheimer’s disease: A systematic review of randomized controlled trials10.1007/s11011-022-01063-9 ↗
36. An Extract of Salvia (Sage) with Anticholinesterase Properties Improves Memory and Attention in Healthy Older Volunteers10.1007/s00213-008-1101-3 ↗
37. Saffron: A Natural Product with Potential Pharmaceutical Applications10.1111/jphp.12456 ↗
38. Saffron in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease: A 16-Week, Randomized and Placebo-Controlled Trial10.1111/j.1365-2710.2009.01133.x ↗
39. A 22-Week, Multicenter, Randomized, Double-Blind Controlled Trial of Crocus sativus in the Treatment of Mild-to-Moderate Alzheimer’s Disease10.1007/s00213-009-1706-1 ↗
40. Comparing the Efficacy and Safety of Crocus sativus L. with Memantine in Patients with Moderate to Severe Alzheimer’s Disease: A Double-Blind Randomized Clinical Trial10.1002/hup.2412 ↗
41. Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial10.3233/JAD-160304 ↗
42. Rhodiola rosea L. and Alzheimer’s Disease: From Farm to Pharmacy10.1002/ptr.5569 ↗
43. Effects of Rhodiola rosea Supplementation on Mental Performance, Physical Capacity, and Oxidative Stress Biomarkers in Healthy Men10.1016/j.jshs.2016.05.005 ↗
44. Rhodiola rosea in Stress Induced Fatigue—A Double Blind Cross-Over Study of a Standardized Extract Shr-5 with a Repeated Low-Dose Regimen on the Mental Performance of Healthy Physicians During Night Duty10.1016/S0944-7113(00)80055-0 ↗
45. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms10.1002/ptr.5486 ↗
46. Efficacy and Tolerability of a Rhodiola rosea Extract in Adults with Physical and Cognitive Deficiencies10.1007/BF02849986 ↗
47. Pharmacodynamic and Clinical Effects of Ginkgo biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer’s Disease10.3233/JAD-231372 ↗
48. The Risk-Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto, and Kava10.7326/0003-4819-136-1-200201010-00010 ↗
49. Liu, L., Zhang, C.S., Zhang, A.L., Cai, Y., and Xue, C.C. (2024). The Efficacy and Safety of Chinese Herbal Medicine for Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. Front. Pharmacol., 15.10.3389/fphar.2024.1341074 ↗
50. Centella asiatica Extract Protects Against Amyloid Β1–40-Induced Neurotoxicity in Neuronal Cells by Activating the Antioxidative Defence System10.1016/j.jtcme.2015.07.002 ↗
51. Positive Modulation of Cognition and Mood in the Healthy Elderly Volunteer Following the Administration of Centella asiatica10.1016/j.jep.2007.11.038 ↗
52. BDNF and Memory Processing10.1016/j.neuropharm.2013.04.024 ↗
53. Mori, Y., Tsuji, M., Oguchi, T., Kasuga, K., Kimura, A., Futamura, A., Sugimoto, A., Kasai, H., Kuroda, T., and Yano, S. (2021). Serum BDNF as a Potential Biomarker of Alzheimer’s Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy. Front. Neurol., 12.10.3389/fneur.2021.653267 ↗
54. Ortega, A., Chernicki, B., Ou, G., and Parmar, M.S. (2024). From Lab Bench to Hope: Emerging Gene Therapies in Clinical Trials for Alzheimer’s Disease. Mol. Neurobiol., online ahead of print.10.1007/s12035-024-04285-3 ↗
55. Chiang, N., Ray, S., Lomax, J., Goertzen, S., Komarnytsky, S., Ho, C.T., and Munafo, J.P. (2021). Modulation of Brain-Derived Neurotrophic Factor (BDNF) Signaling Pathway by Culinary Sage (Salvia officinalis L.). Int. J. Mol. Sci., 22.10.3390/ijms22147382 ↗
56. The Cholinergic Innervation of the Human Cerebral Cortex10.1016/S0079-6123(03)45004-8 ↗
57. Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and its Management using Traditional Medicinal Plants
58. Effects of Sage Extract on Memory Performance in Mice and Acetylcholinesterase Activity10.1016/j.pharma.2015.03.005 ↗
59. Acetylcholine Esterase Inhibitors and Melanin Synthesis Inhibitors from Salvia officinalis10.1016/j.phymed.2016.06.014 ↗
60. Molecular Interaction of Acetylcholinesterase with Carnosic Acid Derivatives: A Neuroinformatics Study10.2174/18715273113126660157 ↗
61. Molecular Recognition of Rosmarinic Acid from Salvia sclareoides Extracts by Acetylcholinesterase: A New Binding Site Detected by NMR Spectroscopy10.1002/chem.201203966 ↗
62. Describing the Sequence of Cognitive Decline in Alzheimer’s Disease Patients: Results from an Observational Study10.3233/JAD-150852 ↗
63. Ross, S.D., Lachmann, T., Jaarsveld, S., Riedel-Heller, S.G., and Rodriguez, F.S. (2023). Creativity Across the Lifespan: Changes with Age and with Dementia. BMC Geriatr., 23, Erratum in BMC Geriatr. 2023, 23, 307.10.1186/s12877-023-03825-1 ↗
64. Mild Cognitive Impairment can be Distinguished from Alzheimer Disease and Normal Aging for Clinical Trials10.1001/archneur.61.1.59 ↗